From reading the genome for risk to rewriting it for cardiovascular health

Dates and Times

Start: 11/18/2026 8:00 AM
End: 11/18/2026 9:00 AM

Objectives

1. To understand the two major genetic models for myocardial infarction risk – monogenic and polygenic
2. To describe how natural resistance mutations lower plasma apoB-containing lipoproteins lifelong in some people and lead to protection against atherosclerotic cardiovascular disease
3. To understand the development of a new class of medicines, which can edit the genome in an adult and potentially lead to permanent lowering of LDL cholesterol after a single dose

Speakers

Accreditation

The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits ^™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.00 MOC points in the The American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.